ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,147Medicare Part D Prescriptions Filled, Including Refills

Rank: 216 out of 2680

$612K Total Retail Price of All Prescriptions

Rank: 218 out of 2680

194 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 194 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

28% of this provider’s 194 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 6,443 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
OMEPRAZOLE 461 354 1 2
LEVOTHYROXINE SODIUM 299 213 2 4
FUROSEMIDE 297 207 3 7
SIMVASTATIN 262 209 4 1
METOPROLOL TARTRATE 213 192 5 8
LISINOPRIL 203 142 6 5
POLYETHYLENE GLYCOL 3350 175 134 7 55
HYDROCODONE-ACETAMINOPHEN 175 113 S3 7 13
AMLODIPINE BESYLATE 158 135 9 3
NOVOLOG 142 112 10 159
JANTOVEN 132 96 11 81
GABAPENTIN 129 78 12 21
LANTUS 112 77 13 70
MORPHINE SULFATE 111 86 S2 14 256
SUBOXONE 99 0 15 124
CARVEDILOL 99 73 15 27
DONEPEZIL HCL 98 98 17 28
TAMSULOSIN HCL 98 82 17 25
MIRTAZAPINE 97 85 19 48
LEVETIRACETAM 93 36 20 94
CEPHALEXIN 88 73 21 132
SPIRIVA 87 55 22 36
FINASTERIDE 86 49 23 80
ADVAIR DISKUS 86 40 23 32
SPIRONOLACTONE 83 53 25 86
CITALOPRAM HBR 82 61 26 22
NYSTOP 82 42 26 183
BACLOFEN 80 37 28 123
LACTULOSE 80 71 28 100
ATORVASTATIN CALCIUM 76 62 30 10
TRAZODONE HCL 74 69 31 60
POTASSIUM CHLORIDE 72 61 32 29
CYMBALTA 71 51 33 56
PRADAXA 70 34 34 203
METOCLOPRAMIDE HCL 70 41 34 150
HYDROCORTISONE 67 33 36 208
CARBIDOPA-LEVODOPA 67 55 36 88
FENTANYL 67 61 S2 36 102
TRAMADOL HCL 64 51 39 33
NAMENDA 64 37 39 43
SPS 62 14 41 354
TRAVATAN Z 61 49 42 234
KLOR-CON M20 61 48 42 101
DIVALPROEX SODIUM 58 45 44 90
LOSARTAN POTASSIUM 58 41 44 18
ESCITALOPRAM OXALATE 58 42 44 82
OLANZAPINE 57 33 47 128
RISPERIDONE 55 42 48 67
PANTOPRAZOLE SODIUM 53 33 49 44
NEXIUM 52 18 50 19
PREDNISONE 52 43 50 45
FAMOTIDINE 51 50 52 65
EXELON 51 26 52 162
ZOLPIDEM TARTRATE 50 18 54 17
QUETIAPINE FUMARATE 50 39 54 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.